StockIQ.techAmgen Inc. (AMGN) Stock Analysis
Free AI-powered analysis and research for Amgen Inc. stock
Sector: Healthcare
AMGN snapshot
Data as of 12 Oct 2026 close. Updated daily.
Amgen Inc. scores 72/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 81% of its 52-week range, up 42.8% over the past year. Latest reported figures show a profit margin of 23.0%, return on equity of 91.5% and revenue growth of +9.5%.
What is driving the score
- RSI Neutral: +5
- Mixed Trend: +0
- MACD Bullish: +8
- Excellent Profit Margin (23.0%): +10
- High Debt (4.90 D/E): -10
- Weak Liquidity (1.37 Current Ratio): -5
- Excellent ROE (91.5%): +8
- High P/B (19.31): -5
- Strong Long-term Uptrend: +8
- Strong Momentum (+42.8% over 1 year): +3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full AMGN report
Amgen Inc. (AMGN) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze AMGN Now →📰 Latest Update
Amgen (AMGN) Advances While Market Declines: Some Information for Investors
Wed, October 7, 2026 at 9:00 PM UTC 2 min read
Amgen (AMGN) has shown resilience by advancing in stock price despite a broader market decline. This performance highlights the company's strong fundamentals and potential for growth, making it an attractive option for investors seeking stability in volatile market conditions. As investors look for opportunities, Amgen's ability to outperform the market could signal confidence in its future prospects.